Oral Abstract Session: Parallel Session 11: Next-generation strategies in cell and gene therapy 1
Friday October 24, 2025 from 08:30 to 10:00
Hall A4
Moderators
Lectures
-
08:30 - 08:50PS11.1 CD133+ Stem Cells Transplantation in Amyotrophic Lateral Sclerosis Hispanic PatientsHector Martinez, Mexico
-
08:50 - 09:02PS11.2 IL-13 enhances islet graft success: a novel approach to promoting transplantation efficiencyProf. Kenneth Brayman, United States
-
09:02 - 09:14PS11.3 In vivo delivery of CRISPR-Cas9 via lipid nanoparticles enhances hepatocyte transplantation by inducing host hepatocyte senescenceDr. Jian Chen, People's Republic of China
-
09:14 - 09:26PS11.4 Oxygen enabled, high capacity, open encapsulation devices implanted subcutaneously vascularized and reversed diabetes in immunodeficient ratsAmy Kelly, United States
-
09:26 - 09:38PS11.5 Globo H Ceramide Promotes Retention and Quality of Tissue Stromal Vascular Fraction GraftDr. Hui-Yun Cheng, Taiwan
-
09:38 - 09:50PS11.6 Targeted Delivery of Alpha-1 Antitrypsin via Nanoparticles Attenuates Cytokine-Induced Inflammation In VitroDr. Giuseppe Pettinato, United States
-
09:50 - 10:02PS11.7 Mocravimod, a novel immunosuppressant, not only suppresses immune rejection but also promotes engraftment of intraportally transplanted islets by its anti-inflammatory and anti-coagulant effectsMr. Shoki Suzuki MD, Japan